Serial Number | 98117779 |
Word Mark | JUNEVITY |
Filing Date | Friday, August 4, 2023 |
Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
Status Date | Tuesday, January 14, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, December 3, 2024 |
Goods and Services | Pharmaceutical preparations for the treatment and prevention of human diseases and disorders, namely, metabolic disease, liver diseases, diabetes, obesity, muscle wasting and frailty, dementia and neurological diseases, skin diseases, chronic kidney disease, inflammatory diseases, and lung diseases; pharmaceutical preparations for the treatment of physiological diseases; pharmaceutical products for cell therapy to treat human diseases and disorders, as well as aging; cell therapy products, namely, pharmaceutical preparations for cell therapy to treat human aging, diseases, and disorders, namely, metabolic disease, liver diseases, diabetes, obesity, muscle wasting and frailty, dementia and neurological diseases, skin diseases, chronic kidney disease, inflammatory diseases, and lung diseases; pharmaceutical preparations for gene therapy to treat human diseases and disorders; pharmaceutical gene therapy preparations to treat human diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for gene and cell therapy |
Goods and Services | Research and development in the field of pharmaceutical development; medical and scientific research and development in connection with cell aging and restoration; research and development of new products in the pharmaceutical and biotechnology fields; development of new technology for others in the fields of gene therapy, genome writing, and genome engineering; scientific research and development in the field of pharmaceutical preparations for gene therapy; scientific research and development in the field of enzyme preparations for gene and cell therapy; research and development services in the field of genomics; medical and scientific research in the fields of genomics; providing medical and scientific research information in the fields of genomics; medical and scientific research in the field of genetics for the purpose of elevating single cell genome variants in order to identify transcription factors; scientific research and development and scientific research consulting, all in the field of genomics; medical research, namely, compiling data for research purposes in the field of genomics; providing medical research information in the field of genomics in relation to disease treatment and aging; providing on-line non-downloadable software for collecting, analyzing, reporting, and tracking data and information in the field of genomics; platform as a service (PAAS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the field of genomics; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the field of genomics; providing temporary use of non-downloadable computer software incorporating machine learning (ML) and artificial intelligence (AI) technology for genomic analysis and sequencing for scientific, medical, and research purposes; providing temporary use of non-downloadable computer software incorporating machine learning (ML) and artificial intelligence (AI) technology for medical and scientific research in the field of genomics; providing temporary use of non-downloadable computer software for providing medical and scientific research information in the field of genomics; providing temporary use of non-downloadable computer software for medical and scientific research in connection with detecting variants in cells to treat disease and mitigate aging; providing temporary use of non-downloadable computer software for research, development and consultancy in the field of genomics; providing temporary use of non-downloadable computer software for compiling data for research purposes in the field of genomics; providing temporary use of non-downloadable computer software for providing medical research information in the field of genomics; providing temporary use of non-downloadable computer software for medical testing, diagnosis, and treatment; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in the field of genomics for the purpose of disease treatment; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in the field of genomics; providing temporary use of non-downloadable computer software for medical and scientific research in connection with aging |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Sunday, September 3, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Sunday, September 3, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Junevity, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | San Mateo, CA 94401 |
Party Name | Junevity, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | San Mateo, CA 94401 |
Event Date | Event Description |
Sunday, September 3, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, August 8, 2023 | NEW APPLICATION ENTERED |
Wednesday, May 22, 2024 | NON-FINAL ACTION WRITTEN |
Wednesday, May 22, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, April 5, 2024 | ASSIGNED TO EXAMINER |
Wednesday, May 22, 2024 | NON-FINAL ACTION E-MAILED |
Tuesday, August 13, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, August 13, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, August 14, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, November 11, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, November 27, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, December 3, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, December 3, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, January 14, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |